GenB M cap 18Bil only those land in johor alone already worth more than 5Bil moreover casino business make huge profit

95% of the participants showing HIGH willingness to continue taking the drug.

This is the final result. Yes or burst!
Yes TP RM8.88
Burst back to RM4.70 only

Thai IR is too far away but still good to go while table gaming bid for RWNYC, taurx, RWG & RWS tourism boost enough for this year earning catalyst.

i'm very agreed with research house point of view, foreign investors tend
to BUY/SELL GENT when the MYR appreciates/depreciates. So just stick to foreign fund when deal with GenB.

very exciting!

Maintain BUYs on GENM, GENS & GENT
For the upcoming lunar year of the Wood Dragon, we update the 3 themes
we flagged last year:- (i) return of Chinese visitors; (ii) downstate casino
license tender in New York City; and (iii) potential legalisation of Thai IRs.
We raise our TPs for GENM to MYR2.93 from MYR2.70, GENS to SGD1.21
from SGD1.16 and GENT to MYR5.84 from MYR5.49 as we roll forward our
valuation base year to end-FY24E from end-FY23E. Our top BUY pick is
GENT as we believe it is also a good proxy to the recovering MYR.

Malaysia Gaming
Enter the dragon in 2024

don't live in the past!

Don't live in the past!

Tomorrow end year 4 witching day, let see how high can GenB go.

What's the next, visa free to GenM, GenS super rich migrant, RMLV F1, RWNYC obtain table games license and taurx. Exiting!

As expected, FF top buyer of GenB with RM40mil net while retailer started to cash out and this is how the share price push higher and higher. Next year on RWG must be very clouded with china, indian and arabian!

So booster, GenM got free visa from china, GenS got super rich china migrant, RWLV got F1. Next year is the show time for GenB

GenS contributed most of the profit and GenM finally turned profit. In sum, anything above RM6Bil revenue is the profit so RM7.37Bil revenue PBT was RM1.3Bil. If RM8Bil next quarter PBT will be RM2Bil. Nice!

GenM+GenP already contributed RM400mil profit for GenB. GenM still a wild card for the jackpot by tomorrow.

FF big return on 15Nov with net buy of 24mil of GenB share from Retailer. Like i mention before this stock is the money game between Foreign and Retailer, only FF will push up the share price. Just follow the money flow and enough the profit.

Those bought during covid just hold it, received div and relax. Other than tat, be patient as share price will rise once foreign fund return.

FI keep selling GenB recently and all taken by Retailer while LI dont hold must GenB due to ESG and Shariah-compliant. So, this is the money game between FI and Retailer. GenB fundamental is ok and on the recovery path but Forex is the problem recently. As long as the outlook of rm is getting weaken FI need to cash out more. Retailer dont push out the price as FI do. In sum, the price will go up only until FI return.

FI already sold 54mil of GenB share in sep and total 205mil YTD. FI always as a main driver of the GenB share price.

very small volume which is just a beginning of the rally

GenB have 3 daughters, RMLV is the younger 1 still drink milk, GenS is the most outstanding while GenM is the elder and very problematic hope will show some good Q2 result

Very impressive, Phase 3 LUCIDITY trial 93% reduction in change over 12 months. I don't know this is good result or not but later GenB share price will decide it. Let see for professional opinion first.

Tomorrow TauRx will be presenting the latest research in neurodegenerative conditions

Developing Topics #83153 - Oral Presentation: Signi­ficant dose-dependent reduction in neuro­filament light chain concentration in plasma with oral tau aggregation inhibitor hydromethylthionine mesylate (data results from LUCIDITY Phase 3 clinical trial) - Presented by Professor Claude Wischik, Co-Founder, Chairman and Chief Executive, TauRx Pharmaceuticals Ltd on Sunday, 16 July: 8:00 – 8:45 am

tis is msci mid yr adjustment. GenB still the favor of fund mgr although Foreign keep selling. All 3 stock Public Bank, Hapseng and GenB which retailer favor have been heavy sell off by foreign for last few month.

Eli Lilly stock soars following data suggesting its Alzheimer's drug can slow illness
https://finance.yahoo.com/video/eli-lilly-stock-soars-following-200523661.html

Taurx Genting will announced final result on 1Jun2023 if not news mean fail otherwise GenB hit the jackpot again

TauRx will release the final and full result on 1Jun2023 and will be very exited moment but whatever is the outcome won't change the momentum and value of GenB as all metrics are pointed to the recovery its business and operation.

All key metrics are now pointed to surge on travel demand according to airline and airport Q result. GenB with 3 mega resort RWS, RWG and RWLV accounted 80% of the overall revenue must have very good earning for the next couple years. Enjoy the show.

Foreigner inst are rational and tried to avoid uncertainty and had been sold GenB for past few days. Next week will see they return. Enjoy the show.

Most listed company do some accounting tactic to avoid prosperity tax like GenB but this figure needed to be balance out some day and 2023 is the chance. No hike of gaming tax and absence of prosperity tax sure will boost the GenB value.

Result very bad due to accounting tactic need to dive deep into SOCF only can understand. Div only 9cent a bit disappoint. But that all in the past 2022 while 2023 and the next must be good show.

Why GenB?
3 Mega resort
RWS - very profitable and political stable
RWG - Monopoly but with political risk, land slide maybe
RWLV - city of gambler
GenP - 200k++hectare of land bank with palm oil
Gen Oil&Gas, power - stable resource and profit
Life science - Wild A card to hit Royal flush and jackpot

Congrats, heavy selling by retailer on 17.2.23 net of RM21mil. As typical bull cycle for blue chip last for 10yrs what do retailer left after RM8.88? We are now in 3rd year of the cycle from lowest price of RM3 GenB 2020.

Congrats, last week retailer net selling 18.2mil of GenB again and all mop up by Local nominees. As long as retailer is dumping mean good news to all. Enjoy the show.

Blue chip bull cycle typically last for 10 yrs but retailer mostly sell on early of the cycle then pick up the share against at the peak @RM8.88. Now we are in the 3rd yrs of the cycle. Good luck

https://www.youtube.com/watch?v=dCXcNht7f_Q
Deputy FM said geg for tobacco black market.

Maybank IB copy cat JP morgan give GenB TP RM8.86 while JP morgan copy paste someone TP RM8.88. Good job and enjoy the show.

Congrats YTD retailer already net selling of rm83mil of GenB share and all taken by local and foreign institutional with price already push up more than 10%. Now all under institutional control and ready to bump up the price. let enjoy the show

20% up after election plus 15cent DPS expected for this Q report is a good start up for GenB. Next recovery from China open border for 2023 and TauRx trial for 2024 with overall Alzheimer’s Therapeutics Market size was valued at USD 4.5Bil in 2022

One way ticket no reverse.

Finally local institutional returned to GenB since yesterday with net buying RM3mil.

2022 nothing is impossible 安华可以做首相messi可以捧杯 2023 GenB target price RM8.8

Just GE15 result out local institution net selling total 93mil of GenB share and all scooped by retailer. Unfortunately, PH form a unity gov and local institution loss big on the bet. Until today only Foreign institution mopped up small portion of 16mil net GenB share.

https://www.investing.com/news/stock-market-news/congressional-report-us-fda-broke-own-protocols-in-approving-biogen-alzheimers-drug-2971153

Biogen set an "unjustifiably high" price by initially setting Aduhelm's price at $56,000 per year despite a lack of demonstrated clinical benefit in a broad patient population, the report said, adding that the company's own internal projections showed it expected the drug to be a burden to Medicare and costly to patients.

We wait for GenB TauRx with highest safety profile.

Penergy already up 30% after election. Cash rich company of 110mil while market cap 270mil and can wait for Block SK433 in Miri which operated by company started to produce oil next year.

PH 82 + BN 26 + Sabah 3 = 111 magic number

Why need to sell to US only 329mil ppl. Just sell to Indonesia can cover 270mil ppl already and some more it is halal for MY as well. Those who lost memory and short memory can buy HMTM at Waston in near future.

Last Corona vaccine dated at 2002 during SARS and failed for period of 20yrs but new mRNA vaccine for covid only took a year from the ground to approval.

Why HMTM need approval from FDA. This drug is made from UK and UK leave EU already so not EMA as well and must be approval from MHRA first.

GenB = A giant conglomerate company, Casino, Plantation, Oil&gas, Utilities and Medical